jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Neck Swelling biopsy - Medium 1-3 cm

Biopsy
image

Report in 288Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Biopsies of neck masses.

₹370₹529

30% OFF

Neck Swelling Biopsy - Medium 1-3 cm

  • Why is it done?
    • Test Purpose: Tissue examination to identify the nature and composition of neck masses ranging from 1-3 cm in size, establishing a definitive diagnosis through histopathological analysis
    • Primary Indications: Unexplained neck lymphadenopathy, thyroid nodules, suspected malignancy, persistent neck masses, enlarged lymph nodes with unclear etiology, and evaluation of suspicious lesions requiring tissue-level diagnosis
    • Clinical Circumstances: When imaging studies (ultrasound, CT, MRI) show indeterminate findings; when fine needle aspiration cytology (FNAC) results are inconclusive; during evaluation for lymphoma, metastatic disease, or thyroid cancer; and when clinical examination reveals persistent neck swelling despite initial conservative management
  • Normal Range
    • Normal Result Definition: Benign tissue histology without malignant cells, reactive hyperplasia, or pathological findings
    • Normal Findings Include: Reactive lymphoid hyperplasia, normal lymph node architecture, benign thyroid follicular tissue, normal connective tissue, absence of necrosis, and no evidence of malignancy
    • Result Interpretation Categories: Benign (normal), Atypical of Undetermined Significance (borderline), Malignancy Suspected (suspicious), or Malignant (diagnostic), following standardized reporting classifications
    • Measurement Units: Histological findings described qualitatively (microscopic examination); specimen size: 1-3 centimeters in maximum dimension
  • Interpretation
    • Benign Results: Indicates reactive lymphadenopathy, inflammatory conditions, or benign lesions; examples include viral lymphadenitis, granulomatous inflammation, or normal lymphoid tissue
    • Atypical/Indeterminate Results: Cellular changes present but insufficient for definitive diagnosis; may suggest early malignancy, specific infections (tuberculosis), or unusual inflammatory conditions requiring repeat biopsy or close clinical follow-up
    • Suspicious for Malignancy: Histological features suggestive of malignancy present but not diagnostic; indicates high probability of cancer (lymphoma, carcinoma, or sarcoma); requires immediate clinical correlation and staging studies
    • Malignant Results: Confirms presence of cancer with specific diagnosis (e.g., lymphoma, squamous cell carcinoma, adenocarcinoma, melanoma); directs treatment planning and prognostic assessment
    • Factors Affecting Results: Specimen adequacy, proper fixation, patient immune status, recent infections, medications (immunosuppressants), prior radiation therapy, and biopsy technique accuracy
  • Associated Organs
    • Primary Organ Systems: Lymphatic system (lymph nodes), thyroid gland, salivary glands, immune system, and soft tissues of the neck
    • Common Malignant Diagnoses: Hodgkin lymphoma, non-Hodgkin lymphoma, metastatic squamous cell carcinoma, thyroid carcinoma (papillary, follicular, medullary), salivary gland malignancies, melanoma, and sarcomas
    • Benign Conditions Diagnosed: Reactive lymphadenitis, infectious mononucleosis, tuberculosis, sarcoidosis, benign thyroid nodules, sialadenitis, and inflammatory pseudotumors
    • Potential Complications: Infection, bleeding, hematoma formation, nerve injury (vagus, hypoglossal, spinal accessory nerves), seeding of malignant cells (rare), and vascular injury; abscess formation if infection develops
  • Follow-up Tests
    • If Malignancy Confirmed: CT or PET-CT scan for staging, bone marrow biopsy (for lymphomas), flow cytometry immunophenotyping, molecular testing for specific mutations, chest imaging, and hepatic function tests
    • If Atypical/Indeterminate: Repeat biopsy (core needle or excisional), immunohistochemistry studies, molecular genetic testing, fluorescence in situ hybridization (FISH), and imaging follow-up in 4-6 weeks
    • If Benign Results: Clinical observation, ultrasound follow-up if indicated, chest imaging if infectious etiology suspected, infectious disease consultation if specific infection identified, and repeat imaging in 3-6 months if mass persists
    • Complementary Imaging: High-resolution ultrasound, MRI for better soft tissue delineation, PET-CT for metabolic activity assessment, and angiography if vascular involvement suspected
    • Specialist Consultations: Oncology (if malignancy), hematology (for lymphomas), endocrinology (for thyroid lesions), infectious disease (for infections), and pathology for additional staining or molecular studies
  • Fasting Required?
    • Fasting Status: Not required; this is a biopsy procedure, not a blood test
    • Pre-procedure Preparation: Light meal 2-4 hours before procedure is acceptable; avoid heavy meals within 4 hours; maintain normal hydration
    • Medications to Avoid: Stop anticoagulants (warfarin) 3-5 days prior; discontinue antiplatelet agents (aspirin, clopidogrel) 5-7 days before procedure; hold NSAIDs for 48 hours pre-procedure; continue essential cardiac medications as directed
    • Pre-procedure Testing: Coagulation studies (PT, PTT, platelet count) if abnormal bleeding history; baseline CBC; imaging studies (ultrasound or CT) to localize lesion; pregnancy test if applicable
    • Special Instructions: Wear comfortable, loose-fitting clothing; avoid wearing jewelry around neck area; inform provider of all allergies (anesthetic sensitivities); arrange for transportation as sedation may be used; sign informed consent acknowledging risks; arrive 15-30 minutes early for check-in

How our test process works!

customers
customers